GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Beta

iDNA Genomics Public (CYS:IDNA) Beta : N/A (As of Mar. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-03-25), iDNA Genomics Public's Beta is Not available.


iDNA Genomics Public Beta Historical Data

The historical data trend for iDNA Genomics Public's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Beta Chart

iDNA Genomics Public Annual Data
Trend
Beta

iDNA Genomics Public Semi-Annual Data
Beta

Competitive Comparison of iDNA Genomics Public's Beta

For the Diagnostics & Research subindustry, iDNA Genomics Public's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iDNA Genomics Public's Beta Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iDNA Genomics Public's Beta distribution charts can be found below:

* The bar in red indicates where iDNA Genomics Public's Beta falls into.



iDNA Genomics Public Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


iDNA Genomics Public  (CYS:IDNA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


iDNA Genomics Public Beta Related Terms

Thank you for viewing the detailed overview of iDNA Genomics Public's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


iDNA Genomics Public Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Evrota 25- 27, Kifissia, GRC, 145 64
iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.

iDNA Genomics Public Headlines